Case Report
Volume: 5 | Issue: 4 | Published: Apr 24, 2021 | Pages: 129 - 132 | DOI: 10.24911/ejmcr/173-1611396460
Case report of primary mesenteric leiomyosarcoma
Authors: Muhammad Areeb Ashfaq , Summaya Saeed , Ammara Salam , Pirhay Fatma , Danish Faheem , Aun Ali Khawaja
Article Info
Authors
Muhammad Areeb Ashfaq
Aga Khan University Hospital, Karachi, Pakistan
Summaya Saeed
Dow University of Health Sciences, Karachi, Pakistan
Ammara Salam
Fazaia Ruth Pfau Medical College, Karachi, Pakistan
Pirhay Fatma
Liaquat University of Medical & Health Sciences, Karachi, Pakistan
Danish Faheem
Ziauddin Medical University, Karachi, Pakistan
Aun Ali Khawaja
Fazaia Ruth Pfau Medical College, Karachi, Pakistan.
Publication History
Received: January 28, 2021
Revised: March 23, 2021
Accepted: March 25, 2021
Published: April 24, 2021
Abstract
Background: Mesenteric Leiomyosarcoma (LMS) is a rare soft tissue tumor that takes its origin from smooth muscle cells, usually mesenteric blood vessels. Immunohistochemical (IHC) staining is deemed necessary for the diagnosis. Surgical resection with negative microscopic margins is the best treatment available, with limited role of chemo and radiotherapy. Case Presentation: We present a case of 46-year-old male who presented with large abdominal mass and obstructive symptoms. Surgical excision was performed and diagnosis of LMS was established on the basis of IHC stains. Currently, the patient is under follow up and has not developed any recurrence. Conclusion: Due to limited cases recorded globally, definitive guidelines for the management of this tumor are lacking. Work needs to be done to explore further about Primary Mesenteric LMS.
Keywords: Leiomyosarcoma, biopsy, large core-needle, mesenchymal tumor, case report, green
